Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 07/02/2020
Closing price: 265.12
|Support price level:||N/A|
|Resistance price level:||$285.00|
|Relative strength index (14-day RSI)||39.8|
- BIIB is one of this month's worst performers with a return of -11.5%, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- BIIB is below its 200-day moving average - additional caution warranted in long positions.
- Price broke below prior support level - a short-term bearish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 10.3% in the next week.
- 22.9% in the next month.
- 94.6% in the next year.